Suppr超能文献

单核细胞趋化蛋白-1在骨巨细胞瘤破骨细胞瘤中的基因表达:可能参与CD68+巨噬细胞样细胞迁移。

Gene expression of monocyte chemoattractant protein-1 in giant cell tumors of bone osteoclastoma: possible involvement in CD68+ macrophage-like cell migration.

作者信息

Zheng M H, Fan Y, Smith A, Wysocki S, Papadimitriou J M, Wood D J

机构信息

Department of Orthopaedic Surgery, University of Western Australia, Nedlands, Australia.

出版信息

J Cell Biochem. 1998 Jul 1;70(1):121-9.

PMID:9632113
Abstract

Giant cell tumor of bone (GCT) is one of a few neoplasms in which the macrophage/osteoclast precursor cells and osteoclast-like giant cells infiltrate the tumor mass. Monocyte chemoattractant protein 1 (MCP-1) is a potent chemotactic factor specific for monocytes. In search of relevant cytokines that may enhance the recruitment of these reactive cells, we evaluated the localization and regulation of MCP-1 mRNA and protein in GCT by using Northern blot analysis, in situ hybridization and immunohistochemistry. We also determined whether conditioned medium obtained from GCT cultures can recruit human peripheral blood monocytes (CD68+) in an in vitro chemotactic assay. Using Northern blot analysis, we detected the specific gene transcript for MCP-1 in all GCT samples tested. In situ hybridization and immunohistochemistry revealed that both MCP-1 gene transcript and protein were consistently present in the cytoplasm of stromal-like tumor cells of GCT. Treatment of mononuclear cells from GCT at third passage with TGF-beta1 for 24 h increased the level of MCP-1 mRNA in a dose-dependent manner, with the maximum effect at 1 ng/ml. Conditioned media from GCT cultures promoted the chemotactic migration of CD68+ peripheral monocytes, an activity which was abolished by the addition of MCP-1 antibody to the conditioned medium. Thus, the results of this study suggest that recruitment of CD68+ macrophage-like cells may be due to the production MCP-1 by stromal-like tumor cells. These CD68+ cells may originate from peripheral blood and could have the capability of further differentiating into osteoclasts in the tumor.

摘要

骨巨细胞瘤(GCT)是少数几种巨噬细胞/破骨细胞前体细胞和破骨细胞样巨细胞浸润肿瘤块的肿瘤之一。单核细胞趋化蛋白1(MCP-1)是一种对单核细胞具有特异性的强效趋化因子。为了寻找可能增强这些反应性细胞募集的相关细胞因子,我们通过Northern印迹分析、原位杂交和免疫组织化学评估了GCT中MCP-1 mRNA和蛋白的定位及调控。我们还在体外趋化试验中确定了从GCT培养物中获得的条件培养基是否能募集人外周血单核细胞(CD68+)。通过Northern印迹分析,我们在所有测试的GCT样本中检测到了MCP-1的特异性基因转录本。原位杂交和免疫组织化学显示,MCP-1基因转录本和蛋白始终存在于GCT基质样肿瘤细胞的细胞质中。用TGF-β1处理第三代GCT单核细胞24小时,MCP-1 mRNA水平呈剂量依赖性增加,在1 ng/ml时达到最大效应。GCT培养物的条件培养基促进了CD68+外周单核细胞的趋化迁移,向条件培养基中添加MCP-1抗体可消除这种活性。因此,本研究结果表明,CD68+巨噬细胞样细胞的募集可能是由于基质样肿瘤细胞产生MCP-1所致。这些CD68+细胞可能起源于外周血,并可能具有在肿瘤中进一步分化为破骨细胞的能力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验